tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Trung Huynh, 15 are a HOLD (38.46%), 21 are a BUY (53.85%), 3 are a SELL (7.69%).
Analyst Trung Huynh, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 48.61% that have a potential upside of 8.99% achieved within 85 days.
Trung Huynh’s has documented 84 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PFE, Pfizer at 30-Apr-2025.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 4/28/2023. The price target of $420 was fulfilled within 5 days with a profit of $29.96 (7.68%) receiving and performance score of 15.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$27.53
$20.18 (274.56%)
$19.07
2 years 4 days ago
(05-May-2023)
0/12 (0%)
$20.09 (270.03%)
Buy
$17.25
$9.9 (134.69%)
$21
2 years 4 days ago
(05-May-2023)
0/6 (0%)
$9.81 (131.85%)
Hold
$18.36
$11.01 (149.80%)
$9.34
2 years 3 months 21 days ago
(18-Jan-2023)
2/6 (33.33%)
$9.15 (99.35%)
46
Hold
$9.09
$1.74 (23.67%)
$12.5
2 years 4 months 6 days ago
(03-Jan-2023)
3/3 (100%)
$0.35 (4.00%)
65
Hold
$9.91
$2.56 (34.83%)
$16.32
2 years 6 months 14 days ago
(25-Oct-2022)
1/5 (20%)
$3.81 (62.46%)
105
Which stock is Trung Huynh is most bullish on?
Which stock is Trung Huynh is most reserved on?
What Year was the first public recommendation made by Trung Huynh?
